SUMINISTRO DEL MEDICAMENTO EXCLUSIVO: FACTOR IX RECOMBINANTE-NONACOG ALFA (BENEFIX)
Awarded
The competition has ended and a winner has been selected.
- Qualification deadline
- May 3,Expired
- Award
Brief
El Servicio Madrileño de Salud, Hospital Universitario La Paz, ha adjudicado un contrato a PFIZER S.L.U. para el suministro del medicamento exclusivo Factor IX Recombinante-Nonacog Alfa (BeneFIX) en España. El contrato tiene una duración de 12 meses y un valor final de 475.156 €. Solo se recibió una oferta para esta adjudicación.
Farmasøytisk engroshandel
Result
- PFIZER S.L.U.Winner
- 1Number of tenders received
- €475,156Contract value
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Servicio Madrileno de Salud, Hospital Universitario La Paz
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Coste
Source
No source found in the documents. Check the weight against the tender documents.
From the notice
SUMINISTRO DEL MEDICAMENTO EXCLUSIVO: FACTOR IX RECOMBINANTE-NONACOG ALFA (BENEFIX)
Contact
contratacion.hulp@salud.madrid.org- Result · PrequalificationType
- MadridLocation
- 33600000Main codePharmaceutical products